CIBC Private Wealth Group LLC Has $14.30 Million Position in Avantor, Inc. (NYSE:AVTR)

CIBC Private Wealth Group LLC trimmed its stake in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 5.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 646,216 shares of the company's stock after selling 34,235 shares during the period. CIBC Private Wealth Group LLC owned about 0.09% of Avantor worth $14,301,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in AVTR. MassMutual Private Wealth & Trust FSB boosted its position in Avantor by 99.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock worth $26,000 after acquiring an additional 625 shares during the last quarter. Smartleaf Asset Management LLC lifted its position in shares of Avantor by 106.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock worth $34,000 after purchasing an additional 830 shares in the last quarter. Global Retirement Partners LLC boosted its holdings in Avantor by 76.7% during the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company's stock worth $52,000 after purchasing an additional 1,067 shares during the last quarter. UMB Bank n.a. grew its position in Avantor by 56.3% in the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company's stock valued at $63,000 after purchasing an additional 1,074 shares in the last quarter. Finally, AlphaQuest LLC acquired a new stake in Avantor in the 4th quarter valued at $65,000. 95.08% of the stock is owned by institutional investors.

Avantor Stock Performance

Shares of NYSE:AVTR traded down $0.53 on Friday, hitting $15.15. The company had a trading volume of 24,521,591 shares, compared to its average volume of 6,633,040. The stock has a market cap of $10.32 billion, a price-to-earnings ratio of 14.56, a P/E/G ratio of 1.55 and a beta of 1.23. The stock has a 50 day moving average price of $17.78 and a 200 day moving average price of $21.00. Avantor, Inc. has a 1-year low of $14.93 and a 1-year high of $28.00. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54.

Remove Ads

Avantor (NYSE:AVTR - Get Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, beating analysts' consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same period last year, the company posted $0.22 EPS. Analysts expect that Avantor, Inc. will post 1.06 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on AVTR shares. Raymond James restated an "outperform" rating and set a $24.00 price objective (down from $26.00) on shares of Avantor in a research note on Monday, February 10th. UBS Group restated a "neutral" rating and issued a $25.00 price target (down from $29.00) on shares of Avantor in a research note on Friday, January 17th. Cowen reaffirmed a "buy" rating on shares of Avantor in a research report on Tuesday, March 18th. Citigroup cut their price objective on Avantor from $22.00 to $18.00 and set a "neutral" rating for the company in a report on Tuesday, March 4th. Finally, Morgan Stanley lowered their target price on shares of Avantor from $27.00 to $25.00 and set an "overweight" rating on the stock in a report on Monday, February 10th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, Avantor currently has a consensus rating of "Moderate Buy" and a consensus price target of $25.50.

Insider Activity

In related news, CAO Steven W. Eck sold 4,907 shares of the business's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the sale, the chief accounting officer now directly owns 40,604 shares in the company, valued at $711,788.12. The trade was a 10.78 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP James Bramwell sold 3,758 shares of the company's stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $65,877.74. Following the completion of the transaction, the executive vice president now directly owns 87,379 shares in the company, valued at approximately $1,531,753.87. This represents a 4.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is owned by company insiders.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.